CAR-T gene therapy for leukemia clears FDA hurdle

Last Updated Jul 13, two thousand seventeen 11:16 AM EDT

A panel of cancer experts has voted unanimously in favor of a leukemia treatment which could be the very first gene therapy available in the U.S.

The Food and Drug Administration advisory panel voted 10-0 on Wednesday to recommend approval of the treatment developed by the University of Pennsylvania and Novartis Corp. Continue reading →